Europe Human Microbiome Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macroeconomic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country-level data:

4. Europe Human Microbiome Market Landscape

4.1 Overview

4.2 PEST Analysis

5. Europe Human Microbiome Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Significant Investments by Key Market Players

5.1.2 Government Initiatives

5.2 Market Restraints

5.2.1 Challenges During Production of Microbiome

5.3 Market Opportunities

5.3.1 Robust Investment in Research and Development

5.4 Future Trends

5.4.1 Emergence of Precision Medicine

5.5 Impact of Drivers and Restraints:

6. Human Microbiome Market – Europe Analysis

6.1 Europe Human Microbiome Market Revenue (US$ Million), 2021–2031

6.2 Europe Human Microbiome Market Forecast Analysis

7. Europe Human Microbiome Market Analysis – by Type

7.1 Product

7.1.1 Overview

7.1.2 Product: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.2 Software and Services

7.2.1 Overview

7.2.2 Software and Services: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

8. Europe Human Microbiome Market Analysis – by Application

8.1 Therapeutics

8.1.1 Overview

8.1.2 Therapeutics: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.2 Diagnostics

8.2.1 Overview

8.2.2 Diagnostics: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.3 Research

8.3.1 Overview

8.3.2 Research: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

9. Europe Human Microbiome Market Analysis – by Disease Type

9.1 Obesity

9.1.1 Overview

9.1.2 Obesity: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.2 Diabetes

9.2.1 Overview

9.2.2 Diabetes: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.3 Autoimmune Disorder

9.3.1 Overview

9.3.2 Autoimmune Disorder: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.4 Cancer

9.4.1 Overview

9.4.2 Cancer: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.5 GIT

9.5.1 Overview

9.5.2 GIT: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

10. Europe Human Microbiome Market – Country Analysis

10.1 Europe

10.1.1 Europe Human Microbiome Market – Revenue and Forecast Analysis – by Country

10.1.1.1 Europe Human Microbiome Market – Revenue and Forecast Analysis – by Country

10.1.1.2 United Kingdom: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.1.1.2.1 United Kingdom: Europe Human Microbiome Market Share – by Type

10.1.1.2.2 United Kingdom: Europe Human Microbiome Market Share – by Product

10.1.1.2.3 United Kingdom: Europe Human Microbiome Market Share – by Application

10.1.1.2.4 United Kingdom: Europe Human Microbiome Market Share – by Disease Type

10.1.1.3 Germany: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.1.1.3.1 Germany: Europe Human Microbiome Market Share – by Type

10.1.1.3.2 Germany: Europe Human Microbiome Market Share – by Product

10.1.1.3.3 Germany: Europe Human Microbiome Market Share – by Application

10.1.1.3.4 Germany: Europe Human Microbiome Market Share – by Disease Type

10.1.1.4 France: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.1.1.4.1 France: Europe Human Microbiome Market Share – by Type

10.1.1.4.2 France: Europe Human Microbiome Market Share – by Product

10.1.1.4.3 France: Europe Human Microbiome Market Share – by Application

10.1.1.4.4 France: Europe Human Microbiome Market Share – by Disease Type

10.1.1.5 Italy: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.1.1.5.1 Italy: Europe Human Microbiome Market Share – by Type

10.1.1.5.2 Italy: Europe Human Microbiome Market Share – by Product

10.1.1.5.3 Italy: Europe Human Microbiome Market Share – by Application

10.1.1.5.4 Italy: Europe Human Microbiome Market Share – by Disease Type

10.1.1.6 Spain: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.1.1.6.1 Spain: Europe Human Microbiome Market Share – by Type

10.1.1.6.2 Spain: Europe Human Microbiome Market Share – by Product

10.1.1.6.3 Spain: Europe Human Microbiome Market Share – by Application

10.1.1.6.4 Spain: Europe Human Microbiome Market Share – by Disease Type

10.1.1.7 Rest of Europe: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.1.1.7.1 Rest of Europe: Europe Human Microbiome Market Share – by Type

10.1.1.7.2 Rest of Europe: Europe Human Microbiome Market Share – by Product

10.1.1.7.3 Rest of Europe: Europe Human Microbiome Market Share – by Application

10.1.1.7.4 Rest of Europe: Europe Human Microbiome Market Share – by Disease Type

11. Industry Landscape

11.1 Overview

11.2 Growth Strategies in the Human Microbiome Market

11.3 Organic Growth Strategies

11.3.1 Overview

11.4 Inorganic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 MaaT Pharma

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Ferring Holdings SA

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 AOBiome Therapeutics Inc

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Finch Therapeutics Group Inc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Financial Overview

12.4.4 SWOT Analysis

12.4.5 Key Developments

12.5 Seres Therapeutics Inc

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Merck & Co Inc

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Yakult Honsha Co., Ltd.

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Rebiotix, Inc.

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 IFF Nutrition & Biosciences

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Synthetic Biologics, Inc.

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About Us

13.2 List of Abbreviations

List of Tables

Table 1. Europe Human Microbiome Market Segmentation

Table 2. Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Table 3. Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Type

Table 4. Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Application

Table 5. Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Disease Type

Table 6. Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Country

Table 7. United Kingdom: Europe Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 8. United Kingdom: Europe Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Product

Table 9. United Kingdom: Europe Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 10. United Kingdom: Europe Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease Type

Table 11. Germany: Europe Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 12. Germany: Europe Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Product

Table 13. Germany: Europe Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 14. Germany: Europe Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease Type

Table 15. France: Europe Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 16. France: Europe Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Product

Table 17. France: Europe Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 18. France: Europe Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease Type

Table 19. Italy: Europe Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 20. Italy: Europe Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Product

Table 21. Italy: Europe Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 22. Italy: Europe Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease Type

Table 23. ADULT OBESITY, 2030

Table 24. CHILD OBESITY, 2030

Table 25. Spain: Europe Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 26. Spain: Europe Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Product

Table 27. Spain: Europe Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 28. Spain: Europe Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease Type

Table 29. Rest of Europe: Europe Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 30. Rest of Europe: Europe Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Product

Table 31. Rest of Europe: Europe Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 32. Rest of Europe: Europe Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease Type

Table 33. Recent Organic Growth Strategies in the Human Microbiome Market

Table 34. Recent Inorganic Growth Strategies in the Human Microbiome Market

Table 35. List of Abbreviations

List of Figures

Figure 1. Europe Human Microbiome Market Segmentation – Country

Figure 2. PEST Analysis

Figure 3. Europe Human Microbiome Market – Key Market Dynamics

Figure 4. Impact Analysis of Drivers and Restraints

Figure 5. Europe Human Microbiome Market Revenue (US$ Million), 2021–2031

Figure 6. Europe Human Microbiome Market Share (%) – by Type (2023 and 2031)

Figure 7. Product: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 8. Software and Services: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 9. Europe Human Microbiome Market Share (%) – by Application (2023 and 2031)

Figure 10. Therapeutics: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 11. Diagnostics: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 12. Research: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 13. Europe Human Microbiome Market Share (%) – by Disease Type (2023 and 2031)

Figure 14. Obesity: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 15. Diabetes: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 16. Autoimmune Disorder: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 17. Cancer: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 18. GIT: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 19. Others: Europe Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 20. Europe Human Microbiome Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 21. United Kingdom: Europe Human Microbiome Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 22. Germany: Europe Human Microbiome Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 23. France: Europe Human Microbiome Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 24. Italy: Europe Human Microbiome Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 25. Spain: Europe Human Microbiome Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 26. Rest of Europe: Europe Human Microbiome Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 27. Growth Strategies in the Human Microbiome Market